18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 16 Sep 2016
Price : $35 *
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use; Proof of concept
- Sponsors Avid Radiopharmaceuticals
- 31 Aug 2016 Status changed from active, no longer recruiting to completed.
- 01 Dec 2015 Planned End Date changed from 1 Oct 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov record.
- 01 Dec 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov record.